Tayside Area Formulary - Medicines

The Tayside Area Formulary contains medicines that have been approved for use in NHS Tayside and is intended to serve as a foundation for prescribing practice across the Health Board area. Formulary medicines are agreed by the NHS Tayside Medicines Advisory Group, in partnership with Managed Clinical Networks and other primary and secondary care specialists. Medicines are included in the formulary on the basis of their clinical efficacy, safety, patient acceptability and cost-effectiveness.

National advice on the use of new medicines is issued from the Scottish Medicines Consortium (SMC).  Medicines that have been accepted for use in NHS Scotland are considered for inclusion in the Tayside formulary as described in CMO letter 2012(1).  Local recommendations for all new medicines,including formulary status,are available via the New Medicines Search Index.

NHS Tayside operates a Policy on the Prescribing of Medicines that are Non-Formulary (including Individual Patient Treatment Requests). This requires the doctor to complete an Individual Patient Treatment Request if he/she wishes to prescribe a medicine that is licensed but is still to be evaluated by the SMC or a medicine that is not recommended for use in NHS Scotland by the SMC. Within this process, the doctor is expected to demonstrate that the patient's clinical circumstances imply that the patient is likely to gain significantly more benefit from the medicine than would normally be expected. Further information on the process that medicines go through before NHS doctors in Scotland can routinely prescribe them is available in the leaflet ‘New medicines in Scotland – who decides what the NHS can provide?’
HM Queen Elizabeth II black and white
NHS Tayside Logo White
Her Majesty Queen Elizabeth II

1926 - 2022